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Background: Peripheral skeletal muscle is altered in patients suffering from emphysema and chronic obstructive
pulmonary disease (COPD). Oxidative stress have been demonstrated to participate on skeletal muscle loss of
several states, including disuse atrophy, mechanical ventilation, and chronic diseases. No evidences have
demonstrated the occurance in a severity manner.
Methods: We evaluated body weight, muscle loss, oxidative stress, and chymotrypsin-like proteolytic activity in the
gastrocnemius muscle of emphysemic hamsters. The experimental animals had 2 different severities of lung
damage from experimental emphysema induced by 20 mg/mL (E20) and 40 mg/mL (E40) papain.
Results: The severity of emphysema increased significantly in E20 (60.52 ± 2.8, p < 0.05) and E40 (52.27 ± 4.7;
crossed the alveolar intercepts) groups. As compared to the control group, there was a reduction on body
(171.6 ± 15.9 g) and muscle weight (251.87 ± 24.87 mg) in the E20 group (157.5 ± 10.3 mg and 230.12 ± 23.52 mg, for
body and muscle weight, respectively), which was accentuated in the E40 group (137.4 ± 7.2 g and 197.87 ± 10.49 mg,
for body and muscle weight, respectively). Additionally, the thiobarbituric acid reactive substances (TBARS), tert-butyl
hydroperoxide-initiated chemiluminescence (CL), carbonylated proteins, and chymotrypsin-like proteolytic activity were
elevated in the E40 group as compared to the E20 group (p < 0.05 for all comparisons). The severity of emphysema
significantly correlated with the progressive increase in CL (r = −0.95), TBARS (r = −0.98), carbonyl proteins (r = −0.99),
and chymotrypsin-like proteolytic activity (r = −0.90). Furthermore, augmentation of proteolytic activity correlated
significantly with CL (r = 0.97), TBARS (r = 0.96), and carbonyl proteins (r = 0.91).
Conclusions: Taken together, the results of the present study suggest that muscle atrophy observed in this model of
emphysema is mediated by increased muscle chymotrypsin-like activity, with possible involvement of oxidative stress
in a severity-dependent manner.
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Emphysema is a form of chronic obstructive pulmonary
disease (COPD), which is associated with high morbidity
and mortality worldwide. Emphysema is primarily caused
by smoking, although environmental pollution and α1-anti-
trypsin deficiency may also lead to its development [1].* Correspondence: faguarnier@uel.br
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reproduction in any medium, provided the orPatients typically present altered muscle mass and exercise
intolerance [2], and this loss of skeletal muscle mass is a
common observation in patients with COPD [1]. Skeletal
muscle atrophy is an important systemic consequence, and
reduced mid thigh muscle cross sectional area has a strong
impact on mortality [3]. Although the biochemical path-
ways engaged in the development of muscle atrophy are
poorly understood, an imbalance between protein break-
down and synthesis, in favor of the former, is believed to
play a role in this process [4]. In addition to muscle weak-
ness [5], human studies demonstrated that emphysema isLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and elevated exercise-induced muscle phosphocreatine
activity [7]. Unfortunately, whether these alterations result
from reduced physical activity or from COPD itself is yet
to be determined in humans. In addition, data about
extension of lung damage and extension of systemic mani-
festations are scarce. Experimental models of pulmonary
emphysema using proteolytic enzymes such as papain or
elastase, either instilled or nebulized into the airways
of animals, are based on imbalanced protective and
aggressive substances in pulmonary tissue. These
models result in morphological and histological alterations
equivalent to those in humans [8]. The inexpensive,
papain-induced emphysema model results in pulmonary
and systemic alterations characteristic of emphysema
patients. Ventilatory mechanical alterations, increased
residual functional capacity, total lung volume, pulmonary
complacence [9], cardiac overload [10], and skeletal
muscle mass loss [11] are previously reported emphysema-
associated alterations.
Mattson and Poole [12] demonstrated that decreased
citrate synthase activity in peripheral skeletal muscle of
emphysemic hamsters was not associated with the level
of animal activity. In addition, the same group of authors
[2] reported increased lipid peroxidation, as assessed by
malondyaldehyde (MDA) and glutathione levels in the
skeletal muscle of hamsters with emphysema. Since the
1990s, investigators have demonstrated that patients
suffering from emphysema, chronic bronchitis, and
asthma have increased lipid peroxidation, a marker of
oxidative stress [13]. Furthermore, previous studies have
indicated that elevated levels of reactive oxygen species
(ROS) may predispose muscle tissue to fatigue [14] and that
ROS are signaling molecules involved in muscle adaptation;
furthermore, redox-sensitive kinases, phosphatases, and
nuclear factor-κB have been implicated in muscle loss [15].
Previous studies have described the connection between
redox signaling and skeletal muscle adaptation in response
to increased muscular activity (i.e., exercise training)
[16,17] and prolonged periods of muscular inactivity
(i.e., immobilization) [18]. Several lines of evidence indicate
that ROS signaling is involved in the regulation of the
ubiquitin–proteasome system. For example, oxidative stress
has been shown to stimulate ubiquitin conjugation to
muscle proteins through the transcriptional regulation of
the enzymes (i.e., E2 and E3 proteins) that conjugate
ubiquitin to muscle proteins to promote proteolysis [19]. In
theory, increased expression of the E2 and E3 proteins in
skeletal muscles would lead to accelerated proteolysis via
the 26S proteasome. Furthermore, evidence indicates that
the 20S (core) proteasome can degrade oxidized proteins
without ubiquitination [20]. Therefore, it is likely that
oxidative stress can accelerate muscle protein breakdown
via both the 20S proteasome (alone) and the 26Sproteasome complex [15]. The 26S proteasome is a 2.5-
MDa multi-protein complex found in both the nucleus
and cytosol of eukaryotic cells; it is comprised of a single
20S core particle and 19S regulatory particles at one or
both ends. Three major proteolytic activities (described as
chymotrypsin-like, trypsin-like, and post-glutamyl peptide
hydrolytic or caspase-like activity) occur in the 20S core.
Together, these 3 activities are responsible for most of
the protein degradation required for maintaining
cellular homeostasis, including degradation of damaged
cellular proteins. This system is also involved in essential
cellular processes such as the response to hypoxemia and
muscle tissue regeneration. Existing evidence links the
activity of the ubiquitin-proteasome system and the
cellular events that occur in the respiratory and peripheral
muscles of COPD patients [21]. Thus far, no studies have
indicated whether proteolytic activity and oxidative stress
are correlated with COPD severity.
To determine whether oxidative stress plays an
important role in the regulation of skeletal muscle mass
in a COPD model and if it is dependent of the severity,
we evaluated body weight, muscle loss, oxidative stress, and
chymotrypsin-like proteolytic activity in gastrocnemius
muscle tissue in hamsters with 2 different severities of
experimental emphysema. This paper reports that emphy-
sema induces increased muscle loss in a way dependent on
lung injury extension. In addition, oxidative stress, protein
degradation, and chymotrypsin-like proteolytic activity
seem to contribute to this mechanism.
Methods
Animals
Adult male Syrian Golden hamsters, weighing 130–150 g,
were used (n = 8/group). The animals were given water
and commercial food (Nuvilab CR1; Nuvital Nutrients Ltd.,
Curitiba, Brazil) ad libitum, and the environment was con-
trolled on a 12-h light/dark cycle. The protocols conformed
to the Guide for the Care and Use of Laboratory Animals
[DHEW Publication No. (NIH) 86–23, Revised 1985, Office
of Science and Health Reports, DRR/NIH, Bethesda, MD
20892], and the study was approved by Ethics Committee
on Animal Experimentation from the Universidade
Estadual de Londrina, Brazil (ref. 5500).
The animals were randomly divided into 3 groups,
according to the instillation procedure and dose of papain
used to induce emphysema. Under deep ketamine/xylazine
anesthesia (150/30 mg/kg im), either saline (0.3 mL/100 g
body weight) or papain (20 or 40 mg/100 g body weight
[Viafarma, São Paulo, Brazil] in 0.3 mL of normal saline)
was instilled intratracheally using a 27-gauge hypodermic
needle, according to the procedure described by Mattson
et al. [2] with modifications. The procedure consists on
making a short cut on the skin of the tracheal region, se-
clusion of muscle layer and trachea, insertion of the
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of the skin. To ensure a uniform papain distribution
throughout the lungs, each hamster was submitted to a
gentle manual negative pressure maneuver. Briefly, just
after papain instillation, in the moment of final expiration,
thorax was momently restrained in order to avoid lung
expansion. After active inspiration, a negative pressure is
generated and thorax released. This maneuver, through
acute differences of pressure, allows complete spread of
papain until distal airways. The 3 groups were labeled as
follows: control + saline (CS), animals instilled with only
approximately 0.3 mL of saline; emphysema 20 mg/mL
(E20), animals instilled with approximately 0.3 mL of
20 mg/mL papain in saline; and emphysema 40 mg/mL
(E40), animals instilled with approximately 0.3 mL of
40 mg/mL papain in saline. After surgery, the animals
were returned to their cages; their appearance and body
weights were monitored daily for the first 2 weeks and
once a week thereafter, for 60 days.
Tissue collection and preparation
Sixty days after papain injection, the hamsters were
weighed and euthanized. The gastrocnemius muscle was
excised, weighed, frozen in liquid nitrogen, and stored
at −86°C until use. The gastrocnemius muscle has
previously been demonstrated as a good indicator of
alterations in the skeletal muscle of emphysemic hamsters
[22], including those in lipid peroxidation [2]. In hamsters,
there is no obvious gross division of fibers in this muscle
[23], and therefore, the whole muscle is typically analyzed.
The middle lobe of the left lung was fixed in 10% for-
malin for morphometric evaluations. For the oxidative
stress analysis, muscles from CS, E20, and E40 mice were
prepared as described above. Tissues were placed on ice
and homogenized for 60-s periods at 60-s intervals in an
Ultraturrax homogenizer containing 10 mg/mL or 50 mg/
mL of tissue in 10 mM KH2PO4/K2HPO4 buffer and
120 mM KCl at pH 7.4. The total homogenate (10 mg/mL)
was used for the tert-butyl hydroperoxide-stimulated
chemiluminescence (CL) and thiobarbituric acid reactive
substances (TBARS) assays. For total protein carbonylation
determination, tissues were treated according to the method
of Reznick and Packer [24], with adaptations as described
below. For chymotrypsin-like activity analysis, during
muscle excision, a segment of the gastrocnemius muscle of
each animal was frozen in liquid nitrogen, pulverized, and
frozen at −86°C. Additionally, the cachexia index was
determined (considering initial and final body weight of the
emphysemic animals and body weight gain in the CS group)
in order to identify a pattern of general wasting [25].
Morphometric analysis
After the middle lobe of the right lung was removed,
samples were fixed in paraformaldehyde for 48 h andembedded in paraffin for histological studies. Paraffin-
embedded tissues were sectioned into ~5 μm per lung.
Sections were stained with hematoxylin and eosin.
To verify emphysema establishment and severity,
alveolar destruction was determined by the number of
times that a predetermined group of coherent lines
(1.25 mm2 of area and 1.50 mm of total length) crossed
the parenchymal structures. The group identifications
were covered, and lung images were captured (5 fields/
section, 3 semi-serial sections/animal) using an optical
microscope (50× magnification). Images were obtained
using a high-resolution camera coupled to the microscope.
The base lines were then superposed onto the images; the
lesser the structures were crossed, the more extensive was
the lesion [8]. An image analysis system (Image-Pro-
Plus 4.0; Media Cybernetics, Silver Spring, MD, USA) was
used to determine and count the number of intersections.
Determination of TBARS
The extent of lipid peroxidation of the muscle homoge-
nates from each group was determined by the TBARS
reaction. MDA formed during peroxidation reacts in the
TBA test to generate a colored product, a (TBA)2–MDA
adduct. In an acid solution, (TBA)2–MDA absorbs light
at 532 nm and is readily extractable by an organic solvent
such as butanol. MDA levels were measured, and the
results were expressed in nmol/g tissue, as described by
Oliveira and Cecchini [26].
Carbonyl protein content
The carbonyl protein content was measured as
described by Reznick and Parker [24], with modifica-
tions. Approximately 200 mg of gastrocnemius muscle
were placed in glass homogenization tubes containing
4 mL of homogenizing buffer (50 mM phosphate buffer,
1 mM Ethylenediamine tetraacetic acid, pH 7.4). Tissue
samples were homogenized and incubated for 15 min
in an ice bath. The samples were centrifuged at 3,000 × g
for 10 min at room temperature (RT), and 1 mL of each
protein extract was placed in glass tubes. A volume of 4
mL of 2,4-dinitrophenylhydrazine (DNPH) solution
prepared in 2.5 N HCl was added to each tube, and the
reaction mixtures were incubated for 1 h at RT, with
vortexing every 15 min. Next, the samples were washed
with 5 mL of 20% trichloroacetic acid (TCA) (w/v) and
centrifuged for 10 min to collect the protein precipitates.
Another wash was performed using 10% TCA, and
protein pellets were dispersed mechanically. Finally, the
pellets were washed 3 times with 4 mL of ethanol-ethyl
acetate (1:1, v/v) to remove free DNPH and lipid
contaminants. The final precipitates were dissolved in 2
mL of 6 M guanidine hydrochloride, and any insoluble
materials were removed by additional centrifugation.
The carbonyl content was calculated by reading the peak
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versus samples treated with only 2.5 M HCl. The following
formula was used to calculate the concentration of carbo-
nyls: C = Abs (355–390nm) × 45.45 nmol/mL, where C is
the concentration of DNPH/mL, and 45.45 is its absorption
coefficient. The procedures were performed in an ice bath
until the TCA wash step. The carbonyl content was
expressed as nmol/mg total protein.
Measurement of tert-butyl hydroperoxide-initiated CL
Reaction mixtures were placed in 2-mL luminescence
tubes containing the following: total muscle homogenate
(8.75 mg/mL), 10 mM KH2PO4/K2HPO4 buffer (with 120
mM KCl, pH 7.4), and 6 mM tert-butyl hydroperoxide, in
a final volume of 1 mL. The tert-butyl hydroperoxide-
initiated CL reaction was assessed using a TD 20/20
luminometer (Turner Designs, Sunnyvale, CA, USA),
with a response range of 300–650 nm. The tubes were
kept in the dark until the assay was carried out in a room
at 33°C [26,27]. For each animal, a 40-min curve, in which
each point represented the differential smoothing of 600
readings, was obtained by interpolation. The results were
expressed in relative light units/g tissue (RLU/g tissue);
after the final calculation, the area, extracted by integral
calculus of each animal curve, were used to determine the
amount of lipid hydroperoxides present in the sample.
Measurement of the total antioxidant capacity of muscle
(TRAP)
Total antioxidant capacity of homogenates prepared as
described before was measured by CL, in a reaction
medium containing 20 μM 2-azo-bis-(2-amidinopropane)
and 200 μM luminol. After maximal emission was
attained, 70 μL of tissue supernatant or trolox were added
to the reaction medium. The time of total quenching was
compared with trolox quenching, and the results were
expressed in μM trolox [28].
Chymotrypsin-like activity
Chymotrypsin-like proteolytic activity was measured
using a Proteasome Glo™ Chymiotrypsin-like Cell Based
Assay kit (Promega, Madison, WI, USA). This kit
estimates the activity of the 20S proteasome; the assay
involves the use of a specific luminogenic substrate
(succinyl-leucine-valine-tyrosine-aminoluciferin) to deter-
mine chymotrypsin-like activity. The proteasome cleavage
of the substrate produces a luminescent signal by the
luciferase contained in the reaction medium. The 3 major
proteolytic activities (chymotrypsin-like, trypsin-like, and
post-glutamyl peptide hydrolytic or caspase-like activity),
occurring within the 20S core of the 26S proteasome com-
plex are responsible for most of the protein degradation,
which includes degradation of damaged cellular proteins.
Therefore, this coupled-enzyme system, with simultaneousproteasome cleavage of substrate and luciferase consump-
tion of the released aminoluciferin, results in a luminescent
signal that can be considered proportional to the amount
of proteasome activity in the muscle tissue.
During muscle excision, a segment of the gastrocne-
mius muscle of each animal was frozen in liquid nitro-
gen, pulverized, and frozen at −86°C. For the assay, 25 mg
of the muscle powder was added to 1 mL of 10mM
KH2PO4, pH 7.4, in 0.9% NaCl and gently homogenized.
Fifty microliter of the resulting muscle homogenate was
pipetted in duplicate onto 96-well microplates, and the
final reagent mixture was added to the medium. After 5
minutes, under light protection, the plate was read. The
luminescent signal was detected with a Glo-Runner
microplate reader luminometer (Turner Designs), and the
results were expressed as RLU/mg tissue.
Protein concentration
The protein concentration was determined by the method
of Lowry et al. [29], with modifications as described by
Miller [30]. This method involved the use of bovine serum
albumin (BSA) as a standard.
Statistical analysis
The results are presented as mean ± standard error of
the mean (SEM) for 8 animals. All values were compared
using one-way analysis of variance followed by Bonferroni’s
multiple comparison test, with p < 0.05 considered
significant. To evaluate the correlation between oxidative
variables and emphysema severity and between oxidative
variables and chymotrypsin-like proteolytic activity, Mean,
SE and N from each group were combined and submitted
to the Pearson’s correlation test in order to establish the
correlations between the variables. Values of p < 0.05 were
considered significant for all analyses.
Results
Emphysema condition
The extent of lung damage in the emphysema groups
was evaluated by the number of crossed alveolar inter-
cepts. No lung injury was detected in the saline-treated
group (CS) relative to a control group (no saline or
papain instillation). Likewise, no difference was observed
in any other parameter that was analyzed in CS animals
(data not shown). In contrast, the E20 and E40 groups
had significantly decreased crossed intercept values
(60.52 ± 2.8 and 52.27 ± 4.7, respectively) as compared
to the CS group (94.36 ± 7.3). The comparison between
E20 and E40 also demonstrated significant differences in
emphysema severity (p < 0.05). Representative images of
lung injury are presented in Figure 1. Table 1 shows that
the final body weight of CS animals (171.6 ± 15.9 g)
increased as compared to the E20 and E40 group ani-




Figure 1 Histological images from lungs of papain- and saline-
treated hamsters. (A) control + saline (CS): animals treated with
approximately 0.3 mL of saline only; (B) emphysema 20 mg/mL (E20):
animals treated with approximately 0.3 mL of 20 mg/mL papain in
saline; and (C) emphysema 40 mg/mL (E40): animals treated with
approximately 0.3 mL of 40 mg/mL papain in saline. Animals were
euthanized after 60 days. Hematoxylin and eosin (H & E) images are
shown at 50× magnification. Alveolar destruction was determined by
the number of times that a predetermined group of coherent lines
(1.25 mm2 of total area and 1.50 mm of total length) crossed the
parenchymal structures. The lesser these structures are crossed, the
more extensive is the lesion.





94.36 ± 7.3 60.52 ± 2.8* 52.27 ± 4.7*, †
Total body weight (g) 171.6 ± 15.9 157.5 ± 10.3 137.4 ± 7.2*, †
CI (%) — 6.28 ± 0.91 9.45 ± 0.76
Gastrocnemius
weight (mg)
251.87 ± 24.87 230.12 ± 23.52 197.87 ± 10.49*, †




CS – Group instilled with 300 μL of NaCl 0.9%; E20 – Group instilled with
300 μL of papain 20 mg/mL in NaCl 0.9%; E40 – Group instilled with 300 μL of
papain 40 mg/mL in NaCl 0.9%. CI – Cachexia index = (initial body weight –
final body weight + body mass gain of CS group) / (initial body weight – body
mass gain of CS group) x 100. *p<0.05 when compared with CS and †p<0.05
when compared with E20 by One way ANOVA followed by Bonferroni’s
multiple comparison test.
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group). The cachexia index (expressed as a percentage)
reflects not only the loss of total body weight but also the
absence of weight gain [25]. This index in the E20 and
E40 groups reduced by 6.28% ± 0.91% and 9.45 ± 0.76%,
respectively, as compared to the CS group. The weight of
the gastrocnemius muscle was significantly different
between the CS (251.87 ± 24.87 mg) and E40 (197.87 ±
10.49 mg) groups, and the E20 (230.12 ± 23.52 mg) and
E40 groups. These results represented an 8.6% muscle loss
in the E20 group and a 21.4% muscle loss in the E40




was used to analyze the integrity of non-enzymatic anti-
oxidant defenses and the levels of lipid hydroperoxides
in muscle homogenate of animals inoculated with tumor
cells. This assay indicates that the increase in CL is
closely related to the oxidative stress previously suffered
by the tissue. It induces the consumption of antioxidants
and augments the formation of lipid hydroperoxides,
which results in increased photon emission [26,31,32].
Figure 2A represents CL areas under the curves extracted
from individual 40 min-CL curves of each animal. When
E20 and E40 were compared with CS (3517.24 ± 365.40
URL/g tissue), both groups presented increased curves
(4268.36 ± 295.63 and 4835.16 ± 178.12 URL/g tissue,
respectively, p<0.001 for both). E20 vs. E40 comparison
also presented significantly differences. Figure 2B reveals
the total antioxidant capacity (TRAP) on gastrocnemius
muscles of emphysema and control hamsters. Interest-
ingly, decreased total oxidant capacity on E20 (0.96 ±
0.37 μM trolox) was observed when compared with CS















































Figure 2 Effect of muscle loss on gastrocnemius muscle lipid hydroperoxide and antioxidant levels in emphysemic hamsters and
controls. (A) Tert-butyl hydroperoxide-initiated chemiluminescence was monitored continuously for 40 min. The area under the curve for each
animal was determined for comparisons between groups. (B) Total Reactive Antioxidant Potential in gastrocnemius muscles of emphysema and
control hamsters. The bars represent the means of 8 animals. Statistical analyses were performed by one-way analysis of variance (ANOVA)
followed by Bonferroni’s multiple comparison test, with p < 0.05 considered significant. *p < 0.001 to CS; #p < 0.001 relative to E20, as detected
by one-way ANOVA followed by Bonferroni’s multiple comparison test.
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p<0.05) when it was compared with CS. When E40 was
compared to E20, it showed an increase of 353.12%.
Figure 3A shows TBARS levels in the CS, E20, and
E40 groups. Only E40 animals (1.12 ± 0.18 nmol MDA/
g tissue) showed increased TBARS relative to the CS
group (0.71 ± 0.15 nmol MDA/g tissue, p < 0.01).
Figure 3B shows the carbonyl protein levels of each
group. Similar to the TBARS data, only E40 animals
(3.88 ± 0.66 nmol carbonyl/mg total proteins) were
significantly different from CS animals (2.67 ± 0.63 nmol
carbonyl/mg total proteins,) in terms of carbonyl proteinlevel. No differences were detected between the E20 and
E40 groups.
Chymotrypsin-like activity
Increase (113.46%) in the chymotrypsin-like activity
was detected in the E40 group (2013.06 ± 394.50 URL/
mg tissue) compared with the CS group (943.53 ±
262.52 URL/mg tissue, p < 0.001); a significant increase
(50.84%) of chymotrypsin-like activity was also
observed in the E40 group as compared to the E20
group (1334.49 ± 285.77 URL/mg tissue, p < 0.001). No




























































Figure 3 Effect of emphysema on skeletal muscle in terms of thiobarbituric acid reactive substances (TBARS) and carbonyl proteins in
hamsters. (A) TBARS levels in muscle homogenates of hamsters treated with 2 different doses of papain. (B) Levels of protein carbonylation in
muscle homogenates from control and emphysema hamsters. Results are presented as mean ± standard error of the mean (SEM; n = 8).
Statistical differences were detected by one-way ANOVA followed by Bonferroni’s multiple comparison test. Control + saline (CS): animals treated
with approximately 0.3 mL of saline only; emphysema 20 mg/mL (E20): animals treated with approximately 0.3 mL of 20 mg/mL papain in saline;
and emphysema 40 mg/mL (E40): animals treated with approximately 0.3 mL of 40 mg/mL papain in saline. *p < 0.001 relative to CS, as detected
by one-way ANOVA followed by Bonferroni’s multiple comparison test.
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in Figure 4.
Correlation analysis
As demonstrated in Table 2, the analysis between
emphysema severity (represented by the number of
crossed alveolar intercepts) and several variables showed
high correlation values (body weight = 0.87, muscle
weight = 0.72, CL = −0.95, TBARS = −0.98, carbonyl






























Figure 4 Chymotrypsin-like proteolytic activity was evaluated in the g
instillation of papain or saline. *p < 0.001 to CS; #p < 0.001 relative to E2
comparison test.activity = −0.90). In addition, chymotrypsin-like proteolytic
activity and the oxidative variables also showed high
correlation (CL = 0.97, TBARS = 0.96, and carbonyl
proteins = 0.91).
Discussion
Emphysema induces human skeletal muscle loss [5], reduc-
tions in locomotory skeletal muscle contractile function
[33], lipid peroxidation, and alterations in the glutathione
redox system in skeletal muscles of hamsters [2]; it alsoE20 E40
*,#
astrocnemius muscle of hamsters subjected to intratracheal
0, as detected by one-way ANOVA followed by Bonferroni’s multiple











Crossed Alveolar Intercept 0.87 0.72 −0.98* −0.99* −0.95* −0.90*
Chymotrypsin-like activity −0.99* −0.97* 0.96* 0.91* −0.97* -
Mean, SE and N from each group were combined and used in order to establish the correlations between the variables. TBARS – Thiobarbituric acid reactive
substances. Positive values mean positive correlation; negative values mean negative correlation, as evaluated by Pearson’s correlation test. * p<0.05.
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hamsters [12]. In patients with COPD, there is a relation-
ship between FEV1 (the most acceptable parameter on
establishment of severity in humans) and the functional
status. Accordingly, a relationship between peripheral
muscle strength and the severity of airflow obstruction, if
present, would support the idea that chronic inactivity and
muscle deconditioning are important in explaining muscle
weakness in patients with COPD [33].
Our results showed significantly impaired crossed
alveolar intercepts in E20 animals, which was worse in
the E40 group. The comparison between E20 and E40 was
also significantly different, showing injury enhancement
on E40. The damaged lungs are shown in tissue micro-
graphs in Figure 1. The total body weight and gastrocne-
mius muscle weight were decreased in the E20 group and
were statistically significant in the E40 as compared to the
CS group. The cachexia index was high in E20 animals, but
higher in the E40 group. A positive correlation between
emphysema severity and both body and muscle weight
indicated a weak relationship between lung damage and
cachexia. Bernard et al. [33] suggested that, in patients with
stable COPD, the muscle contractile apparatus is preserved
due to the fact that loss of muscle mass is proportional to
the reduction in strength. The preferential loss in lower
limb muscle mass and strength in patients, and their
relationship with FEV1 percentage of predicted also
suggest that muscle deconditioning and the related disuse
atrophy are important factors in explaining peripheral
skeletal muscle dysfunction in COPD. Skeletal muscle loss
and its relationship with severity are poorly discussed on
literature. To our knowledge, these factors were not
related with oxidative alterations and their consequences.
Mechanisms underlying muscle wasting observed in
several diseases remain largely unknown. Since ROS are
demonstrated to be involved on cellular adaptation,
recent studies in our laboratory [25] and others [2,15]
have demonstrated the involvement of oxidative stress in
skeletal muscle loss. In the present study, concomitant
muscle wasting and lipid peroxidation indicated that
lipid peroxidation might be an important factor in the
mechanism of muscle protein hyper-catabolism. Tert-butyl
hydroperoxide-initiated CL was originally used to analyze
the integrity of non-enzymatic antioxidant defenses and
the levels of lipid hydroperoxides in muscle homogenates
of animals inoculated with tumor cells. Previous studiesusing this assay indicated that the increase in CL is
closely related to the oxidative stress previously suffered by
the tissue. Oxidative stress induces the consumption of
antioxidants and augments the formation of lipid hydroper-
oxides, which results in increased photon emission [26,31].
TRAP on E20 result is in accordance with CL. Increased
values of CL area and diminished values of TRAP represent
the classic concept of oxidative stress [34]. While CL curves
enhance on E20 the total antioxidant capacity diminishes.
On the contrary, in E40, CL curves and total antioxidant
capacity becomes higher. In respect with this data, Palace
et al. [35] demonstrated that the supply of vitamin A to the
myocardium by storage organs during increased oxidative
stress subsequent to myocardial infarction was showed in
hemodynamically assessed rats using compartment analysis
of a radio-labeled vitamin A. In our study, it seems that the
same phenomenon happens, with a transport of antioxi-
dants stimulated by free radicals damages, which can not
handle the deleterious action of radicals at all.
In addition, we observed a strong association between
chymotrypsin-like activity and lipid peroxidation markers
(CL, TBARS and carbonylated proteins) in this emphysema
model. It appears that ROS contribute to skeletal muscle
dysfunction in a several ways. For example, Brotto and
Nosek [36] demonstrated a blunted Ca2+ release from the
sarcoplasmic reticulum, and Andrade et al. [37] demon-
strated reduced Ca2+ sensitivity in skeletal muscles exposed
to H2O2. ROS have been implicated in enzymatic dysfunc-
tion within the glycolytic pathway, the citric acid cycle, and
the electron transport system, suggesting that elevated ROS
may impair cellular energetics within skeletal muscles [38].
In addition, Mattson et al. [2] demonstrated increased lipid
peroxidation (evaluated by MDA levels) in gastrocnemius
muscles of hamsters with single-dose elastase-induced
emphysema; these findings are in agreement with our
results. Moreover, we further confirmed the association
between oxidative stress and loss of muscle mass and
chymotrypsin-like proteolytic activity by using a sensitive
CL method [26,31,39], which estimates the chain reaction
of lipid peroxidation earlier, i.e., it measures both
membrane lipid hydroperoxide formation and antioxidant
depletion [40,41]. Our results showed a progressive increase
in TBARS and CL, which were strongly correlated with
chymotrypsin-like proteolytic activity and increased tissue
damage. In addition, progressive protein carbonylation was
observed, which was well correlated with chymotrypsin-like
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Mean, SE and N from each group were combined and used
in order to establish the correlations between the variables,
there is no difference when all data are put together and
the comparison is made point-by-point (with each single
animal data put in the analysis as a point), since the calcula-
tion of correlation takes in account the mentioned values
even when row data is used on the calculus.
A previous study demonstrated that treatment of
C2C12 myotube cells with FeSO4/H2O2 caused a signifi-
cant rise in MDA levels, with a concomitant increase in
the catabolism of myofibrillary proteins and expression
of the major components of the ubiquitin-proteasome
pathway [42]. The authors suggested that mild oxidative
stress increases protein degradation in skeletal muscles
by causing upregulation of the ubiquitin-proteasome
proteolytic pathway in this in vitro model. In line with
these findings, in the present study, chymotrypsin-like
proteolytic activity was well correlated with CL, TBARS,
and carbonyl proteins, and a reduction of body and
muscle weight and an increase in emphysema severity
were observed. It is worth considering that increased
MDA levels are associated with increased proteolysis,
which is related to carbonyl proteins levels. It is likely
that when MDA or low-molecular-weight adducts is
present, the level of oxidized proteins increases, and
proteolytic activity could be accelerated, leading to
muscle atrophy. Some authors have demonstrated that
mild oxidative stress induces protein oxidation, with
increased intracellular proteolysis [20,43,44]. Additionally,
it has been postulated that mammalian cells are able to
selectively remove moderately aldehyde-modified pro-
teins from their intracellular protein pools and that the
proteasomal system is responsible for this activity [42].
The 3 major proteolytic activities (chymotrypsin-like,
trypsin-like, and post-glutamyl peptide hydrolytic or
caspase-like activity), occurring within the 20S core of
the 26S proteasome complex are responsible for most
of the protein degradation, which includes degradation
of damaged cellular proteins.
The bulk of oxidized proteins can be degraded by the
proteasomal system [42,45,46], particularly those modified
by aldehydes and peroxides [20,43]. Of note, the assay
employed in our study can be used to measure proteolysis
related to 20S proteasome, and not only the proteasome
connected to ubiquitin-marked proteins. The 20S prote-
asome is also important, as it can degrade oxidized
proteins without ubiquitination [44]. Only Debigaré et al.
[21] demonstrated that ubiquitination and proteolysis
occur in the limb and respiratory muscles of patients with
COPD, although no links were established between these
processes and the oxidative status.
For the first time, the present study demonstrated that
emphysema promotes body weight and skeletal muscleloss in a severity-dependent manner and is related to oxida-
tive stress and chymotrypsin-like proteolytic activity.
Additionally, oxidative stress variables and muscle
chymotrypsin-like proteolytic activity were well correlated.
Thus, it is reasonable to assume that muscle atrophy
observed in this model of emphysema is mediated by
increased muscle proteolytic activity, with possible
involvement of oxidative stress.
Conclusion
In summary, emphysema induces increased muscle loss,
oxidative stress, contractile protein degradation, and
chymotrypsin-like proteolytic activity in a lung injury-
dependent manner. It is possible that this mechanism
can help elucidate the skeletal muscle dysfunction in
animal models of emphysema and also in human
COPD patients, thus contributing to the establishment of
therapeutic countermeasures against emphysema-induced
muscle damage and cachexia.
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